Latest Insider Transactions at International Flavors & Fragrances Inc (IFF)
This section provides a real-time view of insider transactions for International Flavors & Fragrances Inc (IFF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTERNATIONAL FLAVORS & FRAGRANCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTERNATIONAL FLAVORS & FRAGRANCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2023
|
De Villeplee Christophe Fauchon President, Scent |
SELL
Open market or private sale
|
Direct |
1,972
-17.82%
|
$169,592
$86.35 P/Share
|
|
May 04
2023
|
Mark J Costa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+50.0%
|
-
|
|
May 04
2023
|
Gaoxiang Hu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
434
+50.0%
|
-
|
|
May 04
2023
|
Kevin O'Byrne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
262
+50.0%
|
-
|
|
May 04
2023
|
Dawn C Willoughby Director |
BUY
Exercise of conversion of derivative security
|
Direct |
434
+50.0%
|
-
|
|
May 04
2023
|
Barry A. Bruno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,245
+44.8%
|
-
|
|
May 04
2023
|
Christina A Gold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,245
+11.96%
|
-
|
|
Apr 06
2023
|
Gregory L Yep EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-11.28%
|
$66,703
$91.45 P/Share
|
|
Apr 06
2023
|
Gregory L Yep EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,665
+29.07%
|
-
|
|
Apr 06
2023
|
De Villeplee Christophe Fauchon President, Scent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,101
+9.05%
|
-
|
|
Apr 01
2023
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
461
-6.69%
|
$41,490
$90.6 P/Share
|
|
Apr 01
2023
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
1,489
+17.76%
|
-
|
|
Mar 01
2023
|
Frank Clyburn Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-36.05%
|
$43,407
$91.64 P/Share
|
|
Mar 01
2023
|
Frank Clyburn Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,323
+50.0%
|
-
|
|
Feb 19
2023
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
293
-6.22%
|
$28,128
$96.13 P/Share
|
|
Feb 19
2023
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
708
+13.07%
|
-
|
|
Feb 19
2023
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
176
-2.81%
|
$16,896
$96.13 P/Share
|
|
Feb 19
2023
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
584
+8.54%
|
-
|
|
Feb 19
2023
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
177
-3.19%
|
$16,992
$96.13 P/Share
|
|
Feb 19
2023
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
617
+10.01%
|
-
|
|
Jan 24
2023
|
Michael L Ducker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,209
+18.28%
|
-
|
|
Jan 03
2023
|
De Villeplee Christophe Fauchon President, Scent |
BUY
Exercise of conversion of derivative security
|
Direct |
784
+8.04%
|
-
|
|
Jan 03
2023
|
Francisco Fortanet EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,229
-9.91%
|
$229,587
$103.11 P/Share
|
|
Jan 03
2023
|
Francisco Fortanet EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,254
+18.94%
|
-
|
|
Jan 03
2023
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
487
-7.91%
|
$51,135
$105.64 P/Share
|
|
Jan 03
2023
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
1,341
+17.89%
|
-
|
|
Nov 01
2022
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
376
-8.59%
|
$35,720
$95.45 P/Share
|
|
Nov 01
2022
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,041
+19.21%
|
-
|
|
Oct 03
2022
|
Glenn R Richter CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,812
+50.0%
|
-
|
|
Aug 11
2022
|
Francisco Fortanet EVP, Operations |
SELL
Open market or private sale
|
Direct |
10,000
-36.71%
|
$1,250,000
$125.0 P/Share
|
|
Jun 01
2022
|
De Villeplee Christophe Fauchon President, Scent |
SELL
Open market or private sale
|
Direct |
629
-7.14%
|
$83,028
$132.59 P/Share
|
|
May 05
2022
|
Edward D Breen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,089
+41.36%
|
-
|
|
May 05
2022
|
Barry A. Bruno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
289
+50.0%
|
-
|
|
May 05
2022
|
Christina A Gold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,089
+12.08%
|
-
|
|
May 05
2022
|
Ilene S Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,089
+31.72%
|
-
|
|
May 05
2022
|
Matthias Heinzel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,089
+44.76%
|
-
|
|
May 05
2022
|
Kare Schultz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,089
+44.76%
|
-
|
|
May 02
2022
|
De Villeplee Christophe Fauchon President, Scent |
SELL
Open market or private sale
|
Direct |
630
-6.67%
|
$76,230
$121.68 P/Share
|
|
Apr 01
2022
|
Francisco Fortanet EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,912
-6.56%
|
$256,208
$134.33 P/Share
|
|
Apr 01
2022
|
Francisco Fortanet EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,006
+14.66%
|
-
|
|
Apr 01
2022
|
Robert G. Anderson Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
625
-3.6%
|
$83,750
$134.33 P/Share
|
|
Apr 01
2022
|
Robert G. Anderson Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,741
+9.11%
|
-
|
|
Apr 01
2022
|
Nicolas Mirzayantz President, Nourish |
SELL
Payment of exercise price or tax liability
|
Direct |
2,042
-5.08%
|
$273,628
$134.33 P/Share
|
|
Apr 01
2022
|
Nicolas Mirzayantz President, Nourish |
BUY
Exercise of conversion of derivative security
|
Direct |
4,353
+9.78%
|
-
|
|
Apr 01
2022
|
De Villeplee Christophe Fauchon President, Scent |
SELL
Sale (or disposition) back to the issuer
|
Direct |
256
-2.64%
|
$34,304
$134.33 P/Share
|
|
Apr 01
2022
|
De Villeplee Christophe Fauchon President, Scent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,461
+10.82%
|
$145,199
$59.05 P/Share
|
|
Mar 15
2022
|
Robert G. Anderson Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
288
-1.81%
|
$34,560
$120.48 P/Share
|
|
Mar 15
2022
|
Robert G. Anderson Controller |
BUY
Grant, award, or other acquisition
|
Direct |
662
+4.0%
|
-
|
|
Feb 19
2022
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-3.76%
|
$25,380
$135.03 P/Share
|
|
Feb 19
2022
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
585
+10.47%
|
-
|